[HTML][HTML] Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?—Results of the Polish Atrial Fibrillation (POL-AF) …

A Szyszkowska, Ł Kuźma… - International Journal of …, 2022 - mdpi.com
Background: The aim of our study was to assess if patients with AF (atrial fibrillation) and a
history of ischemic stroke (IS) excessively receive reduced doses of NOACs (non-vitamin K …

[引用][C] Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs? Results of the Polish Atrial Fibrillation (POL-AF) …

A Szyszkowska, L Kuzma… - … Research and Public …, 2022 - jglobal.jst.go.jp
Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses
of NOACs?Results of the Polish Atrial Fibrillation (POL-AF) Registry | Article Information | J-GLOBAL …

Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?—Results of the Polish Atrial Fibrillation (POL-AF) Registry

A Szyszkowska, Ł Kuźma, B Wożakowska-Kapłon… - agris.fao.org
Background: The aim of our study was to assess if patients with AF (atrial fibrillation) and a
history of ischemic stroke (IS) excessively receive reduced doses of NOACs (non-vitamin K …

Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?-Results of the Polish Atrial Fibrillation (POL-AF) Registry

A Szyszkowska, Ł Kuźma… - … and public health, 2022 - pubmed.ncbi.nlm.nih.gov
Background The aim of our study was to assess if patients with AF (atrial fibrillation) and a
history of ischemic stroke (IS) excessively receive reduced doses of NOACs (non-vitamin K …

Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?—Results of the Polish Atrial Fibrillation (POL-AF) Registry

A Szyszkowska, Ł Kuźma… - … and Public Health, 2022 - search.proquest.com
Background: The aim of our study was to assess if patients with AF (atrial fibrillation) and a
history of ischemic stroke (IS) excessively receive reduced doses of NOACs (non-vitamin K …

Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?-Results of the Polish Atrial Fibrillation (POL-AF) Registry.

A Szyszkowska, Ł Kuźma… - … Research and Public …, 2022 - europepmc.org
Background The aim of our study was to assess if patients with AF (atrial fibrillation) and a
history of ischemic stroke (IS) excessively receive reduced doses of NOACs (non-vitamin K …

Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?—Results of the Polish Atrial Fibrillation (POL-AF) Registry

A Szyszkowska, Ł Kuźma, B Wożakowska-Kapłon… - IJERPH, 2022 - econpapers.repec.org
Background: The aim of our study was to assess if patients with AF (atrial fibrillation) and a
history of ischemic stroke (IS) excessively receive reduced doses of NOACs (non-vitamin K …

Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?—Results of the Polish Atrial Fibrillation (POL-AF) Registry

A Szyszkowska, Ł Kuźma, B Wożakowska-Kapłon… - IJERPH, 2022 - ideas.repec.org
Background: The aim of our study was to assess if patients with AF (atrial fibrillation) and a
history of ischemic stroke (IS) excessively receive reduced doses of NOACs (non-vitamin K …

[HTML][HTML] Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?—Results of the Polish Atrial Fibrillation (POL-AF) …

A Szyszkowska, Ł Kuźma… - … Research and Public …, 2022 - ncbi.nlm.nih.gov
Background: The aim of our study was to assess if patients with AF (atrial fibrillation) and a
history of ischemic stroke (IS) excessively receive reduced doses of NOACs (non-vitamin K …